Thus, ephrin-B2-targeted therapy might be useful as a prophylactic treatment for lymph node metastasis of OSCC, and if proven effective, in combination with primary treatment. The gene discussed is EFNB2; the disease is metastatic malignant neoplasm in the lymph nodes.